Baird Still Isn't Buying Biogen

By: via Benzinga
While reporting a significant EPS beat for Q2, Biogen Inc (NASDAQ: BIIB) also announced the departure of its CEO. Baird’s Brian ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.